[1]
Leone A. Current approaches to hypertension treatment: are there promising results? J CardiolCurr Res 2015; 3(2): 00098. [DOI: 10.15406/jccr. 2015.03.00098.].
[2]
Leone A. Markers of atherosclerotic disease: What do they mean? Current opinion and future trends. Curr Pharm Des 2016; 22: 7-17.
[3]
Gotto AM Jr, Brinton EA. Assessing low levels of high density lipoprotein cholesterol as a risk factor in coronary heart disease: a working group report and update. J Am Coll Cardiol 2004; 43: 717-24.
[4]
Glueck CJ. Relationship of lipid disorders to coronary heart disease. Am J Med 1983; 74(5A): 10-4.
[5]
Dinu M, Pagliai G, Angelino D, et al. Effects of Popular Diets on Anthropometric and cardiometabolic Parameters: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials. Adv Nutr 202011(4): 815-33.
[6]
Reaven GM. The insulin resistance syndrome: Definition and dietary approaches to treatment. Annu Rev Nutr 2005; 25: 391-406.
[7]
Kendall DM, Sobel BE, Coulston AM, et al. The insulin resistance syndrome and coronary artery disease. Coron Artery Dis 2003; 14: 335-48.
[9]
Ridker PM, Hennekens HL. Haemostatic risk factors for coronary heart disease. Circulation 1991; 83: 1098-100.
[10]
Koenig W. Haemostatic risk factors for cardiovascular disease. Eur Heart J 1998; 19 Suppl C: C39-43.
[11]
Scipioni M, Pedemonte S, Santarelli MF, Landini L. Probabilistic Graphical Models for Dynamic PET: A Novel Approach to Direct Parametric Map Estimation and Image Reconstruction. IEEE Trans Med Imaging 2020; 39(1): 152-60.
[12]
Santarelli MF, Vanello N, Scipioni M, Valvano G, Landini L. New Imaging Frontiers in Cardiology: Fast and Quantitative Maps from Raw Data. Curr Pharm Des 2017; 23(22): 3268-84.